Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany
Sign Up to like & getrecommendations! Published in 2018 at "Parasite"
DOI: 10.1051/parasite/2018064
Abstract: The efficacy of NexGard® and NexGard Spectra® against sarcoptic mange in dogs was evaluated in a clinical field study. Skin scrapings from dogs presenting signs suggestive of sarcoptic mange were examined to confirm infestation. A… read more here.
Keywords: one month; sarcoptic mange; treatment; nexgard spectra ... See more keywords
Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra®) in endemic areas in France and Spain
Sign Up to like & getrecommendations! Published in 2019 at "Parasite"
DOI: 10.1051/parasite/2019001
Abstract: In the past decade, canine thelaziosis due to Thelazia callipaeda has been diagnosed in an increasing number of European countries, with endemic areas being identified. A multi-center field trial was conducted in endemic areas in… read more here.
Keywords: thelazia callipaeda; thelaziosis; endemic areas; nexgard spectra ... See more keywords